These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15259070)

  • 1. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.
    Gong GZ; Jiang YF; He Y; Lai LY; Zhu YH; Su XS
    World J Gastroenterol; 2004 Aug; 10(15):2223-7. PubMed ID: 15259070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation mechanism of HCV NS5A on p53 protein transactivity].
    Gong GZ; Jiang YF; Zhu YH; Su XS
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):162-5. PubMed ID: 12681065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
    Lan KH; Sheu ML; Hwang SJ; Yen SH; Chen SY; Wu JC; Wang YJ; Kato N; Omata M; Chang FY; Lee SD
    Oncogene; 2002 Jul; 21(31):4801-11. PubMed ID: 12101418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.
    Majumder M; Ghosh AK; Steele R; Ray R; Ray RB
    J Virol; 2001 Feb; 75(3):1401-7. PubMed ID: 11152513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
    Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
    J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.
    Qadri I; Iwahashi M; Simon F
    Biochim Biophys Acta; 2002 Oct; 1592(2):193-204. PubMed ID: 12379483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.
    Otsuka M; Kato N; Lan K; Yoshida H; Kato J; Goto T; Shiratori Y; Omata M
    J Biol Chem; 2000 Nov; 275(44):34122-30. PubMed ID: 10924497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of HCV NS5A on p53's inhibition of AFP expression in hepatocellular carcinoma cells].
    Gong GZ; Jiang YF; He Y; Lai LY; Xu Y; Su XS
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):505-8. PubMed ID: 16042885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines.
    Siavoshian S; Abraham JD; Kieny MP; Schuster C
    Arch Virol; 2004 Feb; 149(2):323-36. PubMed ID: 14745598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.
    Kwun HJ; Jung EY; Ahn JY; Lee MN; Jang KL
    J Gen Virol; 2001 Sep; 82(Pt 9):2235-2241. PubMed ID: 11514734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.
    Sabri S; Idrees M; Rafique S; Ali A; Iqbal M
    Int J Infect Dis; 2014 Aug; 25():38-44. PubMed ID: 24845365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase.
    Sarcar B; Ghosh AK; Steele R; Ray R; Ray RB
    Virology; 2004 Apr; 322(1):51-60. PubMed ID: 15063116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of mutant p53 transcription function by ellipticine.
    Peng Y; Li C; Chen L; Sebti S; Chen J
    Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53.
    Tang HY; Zhao K; Pizzolato JF; Fonarev M; Langer JC; Manfredi JJ
    J Biol Chem; 1998 Oct; 273(44):29156-63. PubMed ID: 9786925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 controls hepatitis C virus non-structural protein 5A-mediated downregulation of GADD45α expression via the NF-κB and PI3K-Akt pathways.
    Cheng D; Zhao L; Zhang L; Jiang Y; Tian Y; Xiao X; Gong G
    J Gen Virol; 2013 Feb; 94(Pt 2):326-335. PubMed ID: 23114628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.